Top Quality Anti Estrogens Estriol Raw Powder 99% Purity CAS NO.50-27-1
- FOB Price: USD: 170.00-170.00 /Gram Get Latest Price
- Min.Order: 10 Gram
- Payment Terms: T/T,Other
- Available Specifications:
Top quality(1-100)Gram
- Product Details
Keywords
- Estriol
- Anti Estrogens
- 50-27-1
Quick Details
- ProName: Top Quality Anti Estrogens Estriol Raw...
- CasNo: 50-27-1
- Molecular Formula: C18H24O3
- Appearance: white powder
- Application: Estriol can be used for reducing the v...
- DeliveryTime: 10-12 days
- PackAge: bag
- Port: shanghai
- ProductionCapacity: 10 Kilogram/Day
- Purity: 99%
- Storage: 2-8℃
- Transportation: air
- LimitNum: 10 Gram
Superiority
purity min99%
Large volume discount
Our advantage:
We have PEPTIDES and SARMS WAREHOUSE IN USA and Euro, you can receive order with 3 days without any customs problems.
We offer drop ship to your end clients in worldwide.
Why Choose us:
1). We have our own GMP lab .
2). Warehouses in USA and Euro to support your urgent need.
3). We can customize Peptides and Test Report HPLC and MS are available.
4). / Bank Transfer / Credit Card / Bitcoin / T/T in Advance / LC @ SIGHT / Paypal for your option.
Details
- Product description
Product name |
Estriol |
CAS No. |
50-27-1 |
Molecular Formula |
C18H24O3 |
Molecular weight |
288.38 |
Grade Standard |
Medicine Grade |
COA |
Avaliable |
- Product introduction
Estriol is a natural hormone, which is the metabolite of estradiol in the body. It mainly exists in urine. It is white crystalline powder, insoluble in water, slightly soluble in ethanol, ether, chlorofrm, dione and vegetable oil, but easily soluble in pyrine and alkali hydroxide solution.
Estriol belongs to estrogen drug. It can be used for treating leukopenia, various kinds of menopathy, senile vaginitis, and menopausal syndrome. You may also get temporary breast swelling and lumps, menstrual cycle disorders with self-recovery after stopping the drug for about 1 month. Patients of breast hyperplasia, breast lumps, and cancer potentially being related to female hormone-related cancer, aplastic anemia and liver disease patients should be disabled.